Capio Biosciences and BioView Ltd Announce Collaboration to Develop Integrated Workflow for Sample to Answer Assay of Circulating Tumor Cells
Capio Biosciences and BioView Ltd Announce Collaboration to Develop Integrated Workflow for Sample to Answer Assay of Circulating Tumor cells
Capio Biosciences and BioView agreed to launch a joint study to evaluate the performance of an integrated solution of clinical utility making use of Capio Bioscience’s CapioCyteTM and BioView’s DeNovoTM systems for the detection and characterization of tumor cells originating from prostate cancer stained with specific tumor related biomarkers.